Description
Shweta N. Patel a, 1, Jeanine N. Staples b Linda Duska b
1 , Christine Garcia c, Lindsay Chatfield d, J. Stuart Ferriss e,
a Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America
b Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, United States of America
c Division of Gynecologic Oncology, The Permanente Medical Group, Kaiser Northern California, San Francisco, CA, United States of America
d Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Washington, DC, United States of America
e Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America
Received 31 October 2019, Revised 25 January 2020, Accepted 29 January 2020, Available online 3 April, 2020
Highlights
-
Racial and ethnic minorities have equivalent willingness to participate in cancer clinical trials as White women.
-
Providing educational material may increase willingness to participate in clinical trials.
-
Different tools are needed for recruitment of minorities to clinical trials.
